Company Name:bluebird bio Inc.
CEO: Nick Leschly

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: bluebird bio Inc is a clinical-stage biotechnology company which develops gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy.


Key numbers

Market Capitalization:5424651240
Shares Outstanding: 55331000
Float: 54892225
Next Earning Date:2020-02-19
TTm EPS: -12.9914
TTm Dividend Rate:
200 days moving average:109.72
50 days moving average: 84.27
One day percent Change: -4.32



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,